Company Profile: Akros Pharma, Inc. based in Princeton, New Jersey, is a wholly-owned subsidiary of JT Pharmaceuticals headquartered in Tokyo, Japan. Dedicated to the development of new pharmaceutical products for the global market, the business model is such that novel compounds are developed through Proof-of-Concept (POC) and then out-licensed or partnered with larger, global pharmaceutical companies. The primary therapeutic areas of focus included: Obesity, Dyslipidemia, Osteoporosis, and Diabetes.